Harvard Bioscience, Inc. (HBIO)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Harvard Bioscience, Inc. (HBIO)
Company Performance

Current Price

as of Dec 03, 2024

$2.24

P/E Ratio

N/A

Market Cap

$97.7M

Description

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Metrics

Overview

  • HQHolliston, MA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerHBIO
  • Price$2.24+1.82%

Trading Information

  • Market cap$97.70M
  • Float91.65%
  • Average Daily Volume (1m)197,130
  • Average Daily Volume (3m)140,085
  • EPS-$0.33

Company

  • Revenue$97.73M
  • Rev growth (1yr)-13.38%
  • Net income-$4.80M
  • Gross margin52.03%
  • EBITDA margin0.35%
  • EBITDA$0.08M
  • EV$158.44M
  • EV/Revenue1.62
  • P/EN/A
  • P/S1.00
  • P/B1.50